Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 10/20 | 0.39 |
| ▸ | NQO2 | P16083 | 8/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14337193 | 0.72 | HTR2A (0.51) | BRD4MTNR1BMTNR1ANQO2 | |
| SCHEMBL605742 | 0.68 | HTR2A (0.45) | MTNR1BMTNR1ANQO2 | |
| SCHEMBL4637019 | 0.67 | DRD2 (0.47) | — | |
| SCHEMBL10321961 | 0.67 | DRD2 (0.47) | — | |
| SCHEMBL603697 | 0.67 | MTNR1B (0.43) | MTNR1BMTNR1ANQO2TSHRALDH1A1 | |
| SCHEMBL11493848 | 0.67 | DRD2 (0.51) | BRD4 | |
| SCHEMBL9305716 | 0.67 | BRD4 (0.56) | BRD4 | |
| SCHEMBL10394947 | 0.67 | ACHE (0.53) | MTNR1BMTNR1ANQO2 | |
| Hydrochloric Acid SCHEMBL5433376 | 0.67 | ALDH1A1 (0.38) | BRD4MTNR1BMTNR1ANQO2TSHR | |
| SCHEMBL3315502 | 0.66 | CYP1A2 (0.45) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022238507-A1 | THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS | AWAKN LS EUROPE HOLDINGS LIMITED (IE) | 2022-11-17 | — | — | WO | disclosed |